NewGenIvf Group Limited (NIVF)
USD 0.33
(-23.27%)
USD 0.33
(-23.27%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 42.24 Thousand USD | -399.42% |
| 2022 | -504.9 Thousand USD | -354.03% |
| 2021 | 198.75 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -510.54 Thousand USD | -341.5% |
| 2023 FY | -2.52 Million USD | -399.42% |
| 2023 Q4 | -1.26 Million USD | -235.26% |
| 2023 Q3 | -377.72 Thousand USD | -2.92% |
| 2023 Q2 | -367 Thousand USD | 28.12% |
| 2022 Q2 | -122.69 Thousand USD | 23.33% |
| 2022 Q1 | -160.03 Thousand USD | 0.0% |
| 2022 FY | -504.9 Thousand USD | -354.03% |
| 2022 Q4 | -115.64 Thousand USD | -8.53% |
| 2022 Q3 | -106.55 Thousand USD | 13.16% |
| 2021 Q3 | -80.00 USD | 96.02% |
| 2021 Q2 | -2010.00 USD | 0.0% |
| 2021 FY | 198.75 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alignment Healthcare, Inc. | -127.81 Million USD | 100.033% |
| Clover Health Investments, Corp. | -208.54 Million USD | 100.02% |
| Marpai, Inc. | -26.37 Million USD | 100.16% |